Canine VEGF antibody and antigen (recombinant protein)
Diagnostic anti-Canine VEGF antibodies pairs and antigen for animal health (animal Dog/Canine angiogenesis) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Companion Animal disease testing products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-CAN-VEGF-Ag01 | Canine VEGF | $3090.00 |
GMP-CAN-VEGF-Ab01 | Anti-Canine VEGF mouse monoclonal antibody (mAb) | $3090.00 |
GMP-CAN-VEGF-Ab02 | Anti-Canine VEGF mouse monoclonal antibody (mAb) | $3090.00 |
GMP-CAN-VEGF-Ab03 | Anti-Canine VEGF human monoclonal antibody (mAb) | $3090.00 |
GMP-CAN-VEGF-Ab04 | Anti-Canine VEGF human monoclonal antibody (mAb) | $3090.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. | GMP-CAN-VEGF-Ag01 |
Product Name | Canine VEGF |
Target/Biomarker | Canine VEGF |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Canine VEGF antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in VEGF level test of animal Dog/Canine with angiogenesis. |
Tag | His | Reconized/Reactive Specics | Canine VEGF |
Product description | Recombinant Canine VEGF protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-CAN-VEGF-Ab01,GMP-CAN-VEGF-Ab02 |
Target/Biomarker | Canine VEGF |
Product Name | Anti-Canine VEGF mouse monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Canine VEGF antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine VEGF antibodies in Canine VEGF level test of animal Dog/Canine with angiogenesis. |
Product description | Anti-Canine VEGF mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine VEGF antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-CAN-VEGF-Ab03,GMP-CAN-VEGF-Ab04 |
Target/Biomarker | Canine VEGF |
Product Name | Anti-Canine VEGF human monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Recombinant Canine VEGF antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine VEGF antibodies in Canine VEGF level test of animal Dog/Canine with angiogenesis. |
Product description | Anti-Canine VEGF mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
Canine Vascular Endothelial Growth Factor (cVEGF) stands at the nexus of canine physiology, driving the intricate process of angiogenesis, or blood vessel formation. This remarkable biomarker is encoded by the VEGF-A gene, producing several isoforms with distinct receptor affinities, allowing for precise control of vascular development in dogs.
At its core, cVEGF is a glycoprotein, mainly expressed in endothelial cells—the very cells that line the interior of blood vessels. Its primary mission is to usher in the formation of new blood vessels, ensuring that oxygen and nutrients reach the tissues that need them. This process is not limited to any specific stage of life; rather, it is a continuous, dynamic mechanism required for various physiological phenomena in dogs.
During embryonic development, cVEGF guides the creation of the intricate vascular network that will sustain the growing fetus. In adult dogs, it remains a guardian of health, facilitating wound healing by stimulating the growth of new blood vessels at the site of injury. Additionally, cVEGF plays a pivotal role in reproductive processes, ensuring proper vascularization of the uterus during pregnancy.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.